A Win For ThermoGenesis Holdings, Inc.
ThermoGenesis Holdings, Inc. (THMO:NASDAQ) rocketted at $6.21, a gain of 35.9%. On Wed 29 Jul 20, THMO:NASDAQ touched a New 2-Week Low of $4.57. From Wed 15 Jul 20, the stock recorded 40.00% Up Days and 36.36% Green Days
The stock spiked on Thu 30 Apr 20 at $14.18 with a volume of 13M+, and its share price has been moving sideways in recent weeks.
About ThermoGenesis Holdings, Inc. (THMO:NASDAQ)
ThermoGenesis Holdings, Inc. is clinical-stage biotechnology company. The company is engaged in developing and manufacturing automated blood and bone marrow processing systems that enable the separation, processing, and preservation of cell and tissue therapy products. The company's device division, ThermoGenesis Corp, provides a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology. ThermoGenesis Holdings, Inc.'s clinical development division is leveraging its proprietary AutoXpress technology platform to develop autologous stem cell-based therapies that address significant unmet needs in the immuno-oncology, vascular, cardiology and orthopedic markets.
Top 10 Gainers:
- Precipio, Inc. (PRPO:NASDAQ), 469.11%
- Taoping Inc. (TAOP:NASDAQ), 331.5%
- Liminal BioSciences Inc. (LMNL:NASDAQ), 123.59%
- Edesa Biotech, Inc. (EDSA:NASDAQ), 81.38%
- MOGU Inc. (MOGU:NYSE), 59.09%
- DIRTT Environmental Solutions Ltd. (DRTT:NASDAQ), 50%
- Technical Communications Corporation (TCCO:NASDAQ), 36.67%
- Zion Oil & Gas, Inc. (ZN:NASDAQ), 36.03%
- ThermoGenesis Holdings, Inc. (THMO:NASDAQ), 35.89%
- Pacific Ethanol, Inc. (PEIX:NASDAQ), 34.29%